Ehlers-Danlos Syndromes: Comparison
Please note this is a comparison between Version 2 by Nicole Yin and Version 1 by Marcel Hanisch.

Ehlers–Danlos syndromes (EDS) are a clinically and genetically heterogeneous group of hereditary connective tissue disorders involving joint hyperlaxity, cutaneous hyperelasticity, and tissue fragility.

  • Ehlers Danlos
  • Rare Diseases
  • oral health

1. Introduction

A revised classification containing 13 subtypes was published by the International EDS Consortium, with a number of clinical conditions to guide and improve the diagnosis of each subtype [2][1]. In the European Union, a disease is considered ‘rare’ if it affects fewer than one in two thousand people [3][2]. In the case of EDS, the prevalence varies, depending on the type: between 1:30,000 (classical type) and < 1:1,000,000 (arthrochalasia type), whereas for the rarest form (the periodontitis type), the prevalence is unknown [1][3].

EDS’ oral conditions have been described as periodontitis [2[1][4][5],4,5], temporomandibular dysfunctions [2[1][6],6], bleeding tendencies [7[7][8],8], enamel hypoplasia [2[1][9],9], shape abnormalities of the teeth and changes in the number of teeth [2[1][8],8], a high palate [2[1][10],10], dysgnathia, and malocclusion [2[1][11],11], as well as decreased effects of local anesthesia [12,13][12][13].

2. Latest Research, Data, Model, Management, Applications or Influences or …

Details about which area the research applies to or what kind of problems it can solve. Your insights, or hypotheses if necessary, regarding the research are also welcomed.

References

  1. Fransiska Malfait; Clair Francomano; Peter Byers; John Belmont; Britta Berglund; James Black; Lara Bloom; Jessica M. Bowen; Angela F. Brady; Nigel P. Burrows; et al.Marco CastoriHelen CohenMarina ColombiSerwet DemirdasJulie De BackerAnne De PaepeSylvie Fournel-GigleuxMichael FrankNeeti GhaliCecilia GiuntaRodney GrahameAlan HakimXavier JeunemaitreDiana JohnsonBirgit Juul-KristensenInes Kapferer-SeebacherHanadi KazkazTomoki KoshoMark E. LavalleeHoward LevyRoberto Mendoza-LondonoMelanie PepinF. Michael PopeEyal ReinsteinLeema RobertMarianne RohrbachLynn SandersGlenda J. SobeyTim Van DammeAnthony VandersteenCaroline Van MourikNicol VoermansNigel WheeldonJohannes ZschockeBrad Tinkle The 2017 international classification of the Ehlers-Danlos syndromes.. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 2017, 175, 8-26, 10.1002/ajmg.c.31552.
  2. Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on OrphanMedical Products. Available online: http://ec.europa.eu/health/files/eudralex/vol-1/reg_2000_141_cons-2009-07/reg_2000_141_cons-2009-07_en.pdf (accessed on 9 February 2018)
  3. The Portal for Rare Diseases and Orphan Drugs. Available online: http://www.orpha.net (accessed on 5 May 2019).
  4. Kapferer-Seebacher, I.; Lundberg, P.; Malfait, F.; Zschocke, J. Periodontal manifestations of Ehlers-Danlossyndromes: A systematic review.J. Clin. Periodontol.2017,44, 1088–1100.
  5. Medicina2020,56, 4488 of 95.Hanisch, M.; Hoffmann, T.; Bohner, L.; Hanisch, L.; Benz, K.; Kleinheinz, J.; Jackowski, J. Rare diseases withperiodontal manifestations.Int. J. Environ. Res. Public Health2019,16, 5.
  6. Peter J. Coster; Luc Martens; Anne Paepe; Oral health in prevalent types of Ehlers-Danlos syndromes. Journal of Oral Pathology & Medicine 2005, 34, 298-307, 10.1111/j.1600-0714.2004.00300.x.
  7. Létourneau, Y.; Pérusse, R.; Buithieu, H. Oral manifestations of Ehlers-Danlos syndrome.J. Can. Dent. Assoc.2001,67, 330–334.
  8. Abel, M.D.; Carrasco, L.R. Ehlers-Danlos syndrome: Classifications, oral manifestations, and dentalconsiderations.Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.2006,102, 582–590.
  9. Daniel H. Cohn; Peter H. Byers; Clinical Screening for Collagen Defects in Connective Tissue Diseases. Clinics in Perinatology 1990, 17, 793-809, 10.1016/s0095-5108(18)30546-3.
  10. Fridrich, K.L.; Fridrich, H.H.; Kempf, K.K.; Moline, D.O. D; ental implications in Ehlers-Danlos syndrome:A case report. Oral Surg. Oral Med. Oral Pathol. 1990, 69, 431–435.
  11. Kevin A. Winters; Zhijie Jiang; Weihong Xu; Shibo Li; Zineb Ammous; Parul Jayakar; Klaas J. Wierenga; Re-assigned diagnosis of D4ST1-deficient Ehlers-Danlos syndrome (adducted thumb-clubfoot syndrome) after initial diagnosis of Marden-Walker syndrome. American Journal of Medical Genetics Part A 2012, 158, 2935-2940, 10.1002/ajmg.a.35613.
  12. Arendt-Nielsen, L.; Kaalund, S.; Bjerring, P.; Høgsaa, B. Insufficient effect of local analgesics in Ehlers Danlostype III patients (connective tissue disorder).Acta Anaesthesiol. Scand.1990,34, 358–361.
  13. Berglund, B.; Nordström, G.; Lützén, K. Living a restricted life with Ehlers-Danlos syndrome (EDS).Int. J.Nurs. Stud.2000,37, 111–118.
More